Page CP et al. |
Platelets and asthma. |
1985 |
Lancet |
pmid:2857401
|
Gresele P et al. |
Platelets and asthma. |
1985 |
Lancet |
pmid:2857402
|
Lenihan DJ et al. |
Involvement of platelet activating factor in physiological stress in the lizard, Anolis carolinensis. |
1985 |
Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. |
pmid:2861063
|
Braquet P et al. |
Involvement of platelet activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN 52021. |
1985 |
Lancet |
pmid:2861423
|
McIntyre TM et al. |
Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. |
1985 |
J. Clin. Invest. |
pmid:2862164
|
Archer CB et al. |
Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man. |
1985 |
Br. J. Pharmacol. |
pmid:2862936
|
Bruynzeel PL et al. |
Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan. |
1985 |
FEBS Lett. |
pmid:2995125
|
Sturk A et al. |
Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. |
1985 |
Thromb. Res. |
pmid:2934863
|
Morley J et al. |
Pharmacology of the late response to allergen and its relevance to asthma prophylaxis. |
1985 |
Int. Arch. Allergy Appl. Immunol. |
pmid:3924841
|
Hwang SB et al. |
Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. |
1985 |
Lab. Invest. |
pmid:3925239
|
Valone FH and Johnson B |
Modulation of cytoplasmic calcium in human platelets by the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine. |
1985 |
J. Immunol. |
pmid:2578151
|
Bourgain RH et al. |
The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. |
1985 |
Prostaglandins |
pmid:3931178
|
Ribbes G et al. |
Evidence that biosynthesis of platelet-activating factor (paf-acether) by human neutrophils occurs in an intracellular membrane. |
1985 |
FEBS Lett. |
pmid:3932094
|
GarcÃa-Sáinz JA and Hernández-Sotomayor SM |
Stimulation of hepatic glycogenolysis by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) via cyclooxygenase products. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3933497
|
Barnes PJ |
Mediators and asthma. |
1985 |
Br J Hosp Med |
pmid:3936563
|
Hemmendinger S et al. |
[Physiology of the interactions of blood and the blood vessel wall. Role of pharmacologically active lipids]. |
1985 |
Arch Mal Coeur Vaiss |
pmid:3938941
|
Waku K et al. |
Metabolism of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a precursor of platelet-activating factor in macrophages. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936199
|
Saito K et al. |
Determination of AGEPC generated from human neutrophils and rat skin and muscle tissues by a selected ion monitoring technique of GC/MS. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936200
|
Maes L et al. |
In vivo arterial platelet-vessel wall interaction and thrombosis: induction, on-line registration and ultrastructural control. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3832867
|
Hanahan DJ et al. |
Platelet-activating factor: a unique lipid chemical mediator. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936201
|
Inoue K et al. |
Activation of guinea pig peritoneal macrophages by platelet-activating factor in free form or incorporated into liposomes. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936203
|
Ostermann G et al. |
Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues. |
1985 |
Biomed. Biochim. Acta |
pmid:4004829
|
Touqui L et al. |
Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked. |
1985 |
Biochem. J. |
pmid:4052028
|
Satouchi K et al. |
Evidence for production of 1-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine concomitantly with platelet-activating factor. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:4004866
|
Benveniste J |
Paf-acether (platelet-activating factor). |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3159192
|
Verstraete M et al. |
An overview of antiplatelet and antithrombotic drugs. |
1985 |
Haemostasis |
pmid:3159632
|
Apprill P et al. |
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. |
1985 |
Circulation |
pmid:2988822
|
Zimmerman GA et al. |
Production of platelet-activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin. |
1985 |
Circulation |
pmid:3928193
|
Benveniste J and Chignard M |
A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases? |
1985 |
Circulation |
pmid:3928192
|
Cordón-Cardó C |
[The barley cell or mastocyte: cellular and molecular biology]. |
1985 |
Med Clin (Barc) |
pmid:2580196
|
Disselnkötter H et al. |
[Synthesis of phosphono analogs of 2-O-acetyl-1-O-hexadecyl(octadecyl)-sn-3-glycerylphosphorylcholine (platelet-activating factor)]. |
1985 |
Arch. Pharm. (Weinheim) |
pmid:4051690
|
Ogunbiyi PO and Eyre P |
Pharmacological studies of pulmonary anaphylaxis in vitro: a review. |
1985 |
Agents Actions |
pmid:2420161
|
Robinson M and Snyder F |
Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species. |
1985 |
Biochim. Biophys. Acta |
pmid:4052436
|
Kozlov VK et al. |
[Characteristics of the activation of rabbit platelets induced by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activation factor)]. |
1985 |
Biull Eksp Biol Med |
pmid:4052603
|
Page CP et al. |
Properties of PAF-acether appropriate to a mediator of the inflammatory aspects of asthma. |
1985 |
Int J Tissue React |
pmid:4055261
|
Wardlow ML |
Rapid isocratic procedure for the separation of platelet-activating factor from phospholipids in human saliva by high-performance liquid chromatography. |
1985 |
J. Chromatogr. |
pmid:4055961
|
Hubbard JW et al. |
Cardiac output and peripheral vascular resistance during intravenous infusion of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious normotensive and spontaneously hypertensive rats. |
1985 |
Res. Commun. Chem. Pathol. Pharmacol. |
pmid:4059660
|
Imbs AB et al. |
[Synthesis of a fluorescently-labeled platelet activating factor]. |
1985 |
Bioorg. Khim. |
pmid:4062993
|
Tokumura A et al. |
Gas chromatographic-mass spectrometric analysis of biologically active phospholipids having an sn-2-acetyl group. |
1985 |
J. Chromatogr. |
pmid:4066848
|
Vanhoutte PM and Houston DS |
Platelets, endothelium, and vasospasm. |
1985 |
Circulation |
pmid:3861273
|
Tan EL and Snyder F |
Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by capillary endothelial cells isolated from rat epididymal adipose tissue. |
1985 |
Thromb. Res. |
pmid:4024051
|
Weisman SM et al. |
Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:3862805
|
Morley J et al. |
PAF and airway hyperreactivity. |
1985 |
Lancet |
pmid:2863479
|
Morley J et al. |
Platelets in asthma. |
1985 |
Lancet |
pmid:2863708
|
Snyder F |
Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids. |
1985 Jan-Mar |
Med Res Rev |
pmid:2984489
|
Kozubski W and Stańczyk L |
[Platelet aggregation in patients with migraine during the pain attack and in the pain-free period]. |
1985 Jul-Aug |
Neurol. Neurochir. Pol. |
pmid:4094642
|
Bette-Bobillo P et al. |
Synthesis and characterization of a radioiodinated, photoreactive and physiologically active analogue of platelet activating factor. |
1985 Jun-Jul |
Chem. Phys. Lipids |
pmid:4042252
|
Leprán I and Lefer AM |
Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia. |
1985 Mar-Apr |
Basic Res. Cardiol. |
pmid:4039929
|
Feuerstein G et al. |
Thyrotropin-releasing hormone blocks the hypotensive effects of platelet-activating factor in the unanesthetized guinea pig. |
1985 Mar-Apr |
J. Cardiovasc. Pharmacol. |
pmid:2581089
|
Mencia-Huerta JM |
Possible role of the T-cell-factor-dependent mast cell subclass in the generation of leukotrienes from lung. |
1985 Sep-Oct |
Ann. Inst. Pasteur Immunol. |
pmid:3878684
|
Masugi F et al. |
Role of acetyl glyceryl ether phosphorylcholine in blood pressure regulation in rats. |
1985 Sep-Oct |
Hypertension |
pmid:4030044
|
Prunieras M |
Melanocytes, melanogenesis, and inflammation. |
1986 |
Int. J. Dermatol. |
pmid:2433237
|
Schleimer RP et al. |
Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. |
1986 |
J. Immunol. |
pmid:3082976
|
Nunez D et al. |
Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. |
1986 |
Eur. J. Pharmacol. |
pmid:3086108
|
Mastacchi R et al. |
Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets. |
1986 |
Agents Actions |
pmid:3518359
|
Simmet T and Peskar BA |
Eicosanoids and the coronary circulation. |
1986 |
Rev. Physiol. Biochem. Pharmacol. |
pmid:3520775
|
Conrad GW and Rink TJ |
Platelet activating factor raises intracellular calcium ion concentration in macrophages. |
1986 |
J. Cell Biol. |
pmid:3733874
|
Moudgil GC |
Anaesthesia and allergic drug reactions. |
1986 |
Can Anaesth Soc J |
pmid:3521800
|
Imura Y et al. |
Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988. |
1986 |
Life Sci. |
pmid:3741541
|
Foegh ML et al. |
Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor. |
1986 |
Transplantation |
pmid:3523888
|
Kertscher HP and Ostermann G |
[Synthesis and thrombocyte aggregating action of stereoisomers of PAF-acether]. |
1986 |
Pharmazie |
pmid:3786385
|
Rampart M and Williams TJ |
Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. |
1986 |
Am. J. Pathol. |
pmid:3524253
|
Powling MJ and Hardisty RM |
Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+. |
1986 |
Thromb. Res. |
pmid:3787566
|
Siffert W et al. |
Inhibition of platelet aggregation by amiloride. |
1986 |
Thromb. Res. |
pmid:3787567
|
Whittle BJ et al. |
Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa. |
1986 |
Am. J. Physiol. |
pmid:3789144
|
Wardlaw AJ et al. |
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. |
1986 |
J. Clin. Invest. |
pmid:3023451
|
O'Flaherty JT et al. |
Metabolism of 5-hydroxyicosatetraenoate by human neutrophils: production of a novel omega-oxidized derivative. |
1986 |
J. Immunol. |
pmid:3095426
|
Villamediana LM et al. |
Effects of the platelet-activating factor antagonist BN 52021 on the hemodynamics of rats with experimental cirrhosis of the liver. |
1986 |
Life Sci. |
pmid:3755490
|
Garay R and Braquet P |
Involvement of K+ movements in the membrane signal induced by PAF-acether. |
1986 |
Biochem. Pharmacol. |
pmid:3755602
|
Pfueller SL and David R |
Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia. |
1986 |
Br. J. Haematol. |
pmid:3756098
|
Hoffman DR et al. |
Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells. |
1986 |
Cancer Res. |
pmid:3756924
|
Sage SO and Rink TJ |
Effects of ionic substitution on [Ca2+]i rises evoked by thrombin and PAF in human platelets. |
1986 |
Eur. J. Pharmacol. |
pmid:3758190
|
Chignard M et al. |
Use of steroidal antiinflammatory drug provides further evidence for a potential role of PAF-acether in bronchial anaphylaxis. |
1986 |
Int. Arch. Allergy Appl. Immunol. |
pmid:3759260
|
Becker EL et al. |
Pertussis toxin as a probe of neutrophil activation. |
1986 |
Fed. Proc. |
pmid:3011523
|
Schlondorff D et al. |
Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells. |
1986 |
Biochem. Biophys. Res. Commun. |
pmid:3099783
|
Okayasu T et al. |
Metabolism of platelet-activating factor in primary cultured adult rat hepatocytes by a new pathway involving phospholipase C and alkyl monooxygenase. |
1986 |
Biochim. Biophys. Acta |
pmid:3947669
|
Baranes J et al. |
The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021. |
1986 |
Pharmacol Res Commun |
pmid:3763677
|
Cirino M et al. |
A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. |
1986 |
Prostaglandins |
pmid:3763941
|
Wallace JL and Whittle BJ |
Profile of gastrointestinal damage induced by platelet-activating factor. |
1986 |
Prostaglandins |
pmid:3763942
|
Burhop KE et al. |
Platelet-activating factor increases lung vascular permeability to protein. |
1986 |
J. Appl. Physiol. |
pmid:3804927
|
Schleimer RP et al. |
Characterization of inflammatory mediator release from purified human lung mast cells. |
1986 |
Am. Rev. Respir. Dis. |
pmid:3485946
|
Okamoto M et al. |
Studies of platelet activating factor (PAF) antagonists from microbial products. II. Pharmacological studies of FR-49175 in animal models. |
1986 |
Chem. Pharm. Bull. |
pmid:2421924
|
Herrmann DB et al. |
Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages. |
1986 |
Biochim. Biophys. Acta |
pmid:3947667
|
Robertson DN and Smith GM |
CV3988 inhibits in vivo platelet aggregation induced by PAF-acether and collagen. |
1986 |
Eur. J. Pharmacol. |
pmid:3709663
|
Bussolino F et al. |
Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells. |
1986 |
Pharmacol Res Commun |
pmid:3490673
|
Yoshida J et al. |
A platelet-aggregating and hypotensive phospholipid isolated from bovine brain. |
1986 |
J. Pharm. Pharmacol. |
pmid:2880959
|
Di Marzo V et al. |
The effect of vasoactive intestinal peptide and calcitonin gene-related peptide on peptidoleukotriene release from platelet activating factor stimulated rat lungs and ionophore stimulated guinea pig lungs. |
1986 |
Biochem. Int. |
pmid:2432897
|
Ramesha CS and Pickett WC |
Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes. |
1986 |
J. Biol. Chem. |
pmid:3096991
|
Chignard M et al. |
Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin). |
1986 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:3464972
|
Hahn HL et al. |
Effects of platelet activating factor on tracheal mucus secretion, on airway mechanics and on circulating blood cells in live ferrets. |
1986 |
Eur J Respir Dis Suppl |
pmid:3465554
|
Morley J and Sanjar S |
Ketotifen and asthma. |
1986 |
N. Z. Med. J. |
pmid:3466080
|
Page CP |
Platelet activating factor, ketotifen and asthma. |
1986 |
N. Z. Med. J. |
pmid:3466093
|
Kloprogge E and Akkerman JW |
Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms. |
1986 |
Biochem. J. |
pmid:3101672
|
Etienne A et al. |
Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. |
1986 |
Agents Actions Suppl. |
pmid:3468781
|
Sanchez Crespo M et al. |
Evidence of a role for PAF-acether in the pathophysiology of the shock state. |
1986 |
Pharmacol Res Commun |
pmid:3774844
|
Adnot S et al. |
Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. |
1986 |
Pharmacol Res Commun |
pmid:3774845
|
Rainsford KD |
Relative roles of leukotrienes and platelet activating factor in experimentally-induced gastric ulceration. |
1986 |
Pharmacol Res Commun |
pmid:3774846
|
Page CP and Morley J |
Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma. |
1986 |
Pharmacol Res Commun |
pmid:3774847
|
Haye-Legrand I et al. |
Production of PAF-acether and leukotrienes by cultured mouse macrophages. |
1986 |
Pharmacol Res Commun |
pmid:3774848
|
Dupont L et al. |
Crystal and molecular structure of BN 52021, a PAF-acether antagonist. Comparison with the conformation of Kadsurenone and related compounds. |
1986 |
Pharmacol Res Commun |
pmid:3774849
|